We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study.
- Authors
Litwin, Alain H; Shafner, Laura; Norton, Brianna; Akiyama, Matthew J; Agyemang, Linda; Guzman, Mercedes; Vera, Tatiana; Heo, Moonseong
- Abstract
This study evaluated health outcomes among people who inject drugs who are infected with hepatitis C virus using an artificial intelligence platform. Mean (SD) cumulative adherence (visual confirmation of administration) was 91.3% (10.5%). Most subjects (88.2%) achieved ≥80% adherence to treatment, and 88.2% (15 of 17) achieved a sustained virologic response.
- Subjects
PATIENT compliance; ARTIFICIAL intelligence; HEPATITIS C virus; PILOT projects
- Publication
Open Forum Infectious Diseases, 2020, Vol 7, Issue 8, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofaa290